T1	Participants 153 202	patients with positive sentinel lymph nodes (SLN)
T2	Participants 401 455	patients treated in a referral cancer center in Brazil
T3	Participants 465 580	Patients with stage I/II melanoma, consecutively submitted to a SLN procedure by the same surgeon from 2000 to 2006
T4	Participants 836 902	Of 381 patients who underwent SLN biopsy, 103 (27%) were positive.
